BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 19135712)

  • 21. Translational research in the Gynecologic Oncology Group: evaluation of ovarian cancer markers, profiles, and novel therapies.
    Darcy KM; Birrer MJ
    Gynecol Oncol; 2010 Jun; 117(3):429-39. PubMed ID: 20233625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in prostatic adenocarcinoma.
    El-Gohary YM; Silverman JF; Olson PR; Liu YL; Cohen JK; Miller R; Saad RS
    Am J Clin Pathol; 2007 Apr; 127(4):572-9. PubMed ID: 17369132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD105 is a more appropriate marker for evaluating angiogenesis in urothelial cancer of the upper urinary tract than CD31 or CD34.
    Miyata Y; Sagara Y; Watanabe S; Asai A; Matsuo T; Ohba K; Hayashi T; Sakai H
    Virchows Arch; 2013 Nov; 463(5):673-9. PubMed ID: 23975255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between the N-terminally truncated (DeltaN) p63alpha (DeltaNp63alpha) isoform and debulking status, VEGF expression and progression-free survival in previously untreated, advanced stage epithelial ovarian cancer: A Gynecologic Oncology Group study.
    Jewell EL; Darcy KM; Hutson A; Lee PS; Havrilesky LJ; Grace LA; Berchuck A; Secord AA
    Gynecol Oncol; 2009 Dec; 115(3):424-9. PubMed ID: 19767063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical expression of endoglin offers a reliable estimation of bone marrow neoangiogenesis in multiple myeloma.
    Alexandrakis MG; Neonakis IK; Pappa CA; Konsolas I; Kokonozaki M; Vyzoukaki R; Soundoulounaki S; Xekalou A; Sfiridaki K; Tsirakis G
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1503-9. PubMed ID: 25773125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.
    Basilio-de-Oliveira RP; Pannain VL
    World J Gastroenterol; 2015 Jun; 21(22):6924-30. PubMed ID: 26078569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eukaryotic initiation factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer.
    Zhou S; Wang GP; Liu C; Zhou M
    BMC Cancer; 2006 Sep; 6():231. PubMed ID: 17010208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VEGF and bFGF expression and microvessel density of maxillary sinus squamous cell carcinoma in relation to p53 status, spontaneous apoptosis and prognosis.
    Bandoh N; Hayashi T; Takahara M; Kishibe K; Ogino T; Katayama A; Imada M; Nonaka S; Harabuchi Y
    Cancer Lett; 2004 May; 208(2):215-25. PubMed ID: 15142681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in esophageal adenocarcinoma.
    Saad RS; El-Gohary Y; Memari E; Liu YL; Silverman JF
    Hum Pathol; 2005 Sep; 36(9):955-61. PubMed ID: 16153457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic value of endoglin (CD105) expression in ovarian carcinoma.
    Taskiran C; Erdem O; Onan A; Arisoy O; Acar A; Vural C; Erdem M; Ataoglu O; Guner H
    Int J Gynecol Cancer; 2006; 16(5):1789-93. PubMed ID: 17009973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microvessel density: correlation with 18F-FDG uptake and prognostic impact in lung adenocarcinomas.
    Guo J; Higashi K; Ueda Y; Oguchi M; Takegami T; Toga H; Sakuma T; Yokota H; Katsuda S; Tonami H; Yamamoto I
    J Nucl Med; 2006 Mar; 47(3):419-25. PubMed ID: 16513610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome.
    Martone T; Rosso P; Albera R; Migliaretti G; Fraire F; Pignataro L; Pruneri G; Bellone G; Cortesina G
    Oral Oncol; 2005 Feb; 41(2):147-55. PubMed ID: 15695116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions.
    Ding S; Li C; Lin S; Yang Y; Liu D; Han Y; Zhang Y; Li L; Zhou L; Kumar S
    Hum Pathol; 2006 Jul; 37(7):861-6. PubMed ID: 16784986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endoglin (CD105) expression and angiogenesis status in small cell lung cancer.
    Takase Y; Kai K; Masuda M; Akashi M; Tokunaga O
    Pathol Res Pract; 2010 Nov; 206(11):725-30. PubMed ID: 20619547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of selected angiogenesis markers and modulators in pre-, peri- and postmenopausal women with ovarian cancer].
    Bednarek W; Mazurek M; Cwiklińska A; Barczyński B
    Ginekol Pol; 2009 Feb; 80(2):93-8. PubMed ID: 19338204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor Microvessel Density as a Potential Predictive Marker for Bevacizumab Benefit: GOG-0218 Biomarker Analyses.
    Bais C; Mueller B; Brady MF; Mannel RS; Burger RA; Wei W; Marien KM; Kockx MM; Husain A; Birrer MJ;
    J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of the prognostic significance of endoglin (CD105) in clear cell renal cell carcinoma using automated image analysis.
    Dubinski W; Gabril M; Iakovlev VV; Scorilas A; Youssef YM; Faragalla H; Kovacs K; Rotondo F; Metias S; Arsanious A; Plotkin A; Girgis AH; Streutker CJ; Yousef GM
    Hum Pathol; 2012 Jul; 43(7):1037-43. PubMed ID: 22204709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of CD 105 expression for tumour angiogenesis and prognosis in endometrial carcinomas.
    Salvesen HB; Gulluoglu MG; Stefansson I; Akslen LA
    APMIS; 2003 Nov; 111(11):1011-8. PubMed ID: 14629267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal expression of Endoglin and its receptor complex (TGF-β1 and TGF-β receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosa.
    Bellone G; Gramigni C; Vizio B; Mauri FA; Prati A; Solerio D; Dughera L; Ruffini E; Gasparri G; Camandona M
    Int J Oncol; 2010 Nov; 37(5):1153-65. PubMed ID: 20878063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis.
    Mazibrada J; Rittà M; Mondini M; De Andrea M; Azzimonti B; Borgogna C; Ciotti M; Orlando A; Surico N; Chiusa L; Landolfo S; Gariglio M
    Gynecol Oncol; 2008 Jan; 108(1):112-20. PubMed ID: 17936343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.